The expression level of CD52 was related to the prognosis of breast cancer patients. Tumor-infiltrating immune cell analysis showed the relationship between CD52 expression and CD8+ T cells, activated memory CD4+ T cells, macrophage M1, and gamma delta T cells. This evidence concerns the gene CD8A and breast carcinoma.